Press Releases Optomed Oyj

Equities

Market Closed - Nasdaq Helsinki Other stock markets 16:29:39 10/05/2024 BST			5-day change	1st Jan Change
5.47 ^EUR	+2.05%		+10.62%	+47.24%

05-07	Transcript : Optomed Oyj, Q1 2024 Earnings Call, May 07, 2024
05-07	Optomed Oyj Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Decisions of the Annual General Meeting and Board of Directors	06:01pm	AQ
Optomed Oyj : Interim Report, January - March 2024	05-07	PU
Optomed Oyj : Interim Report, January - March 2024, presentation	05-07	PU
Optomed Plc: Interim Report, January - March 2024	05-07	AQ
Inside information, Optomed Aurora with AEYE has received FDA clearance in the US	04-30	AQ
No updates on the Optomed Aurora AEYE FDA clearance process	04-29	AQ
Notice of the Annual General Meeting of Optomed Plc	04-12	AQ
Optomed Oyj : Plc - Managers' transactions - Himberg	03-06	PU
Optomed Plc - Managers' transactions - Knuutti	03-04	AQ
Optomed Plc - Managers' transactions - Piila	03-04	AQ
Optomed Plc - Managers' transactions - Myllylä	03-04	AQ
Optomed Plc - Managers' transactions - Himberg	03-04	AQ
Optomed Annual Report 2023 published	02-29	AQ
Optomed Plc: Financial Statements Bulletin, January - December 2023	02-15	AQ
Proposal of Optomed's Nomination Board	01-10	AQ
Disclosure under Chapter 9, Section 10 of the Securities Markets Act regarding change in holdings	12-04	AQ
Optomed Plc: Interim report, January - September 2023	11-03	AQ
Disclosure under Chapter 9, Section 10 of the Securities Markets Act regarding change in holdings	11-02	AQ
Optomed's January-September 2023 interim report will be published on 3 November 2023	30/10/23	AQ
Optomed Oyj : Interviewing our new CEO Juho Himberg	11/10/23	PU

No results for this search